MedPage Today September 26, 2024
— Other than staying on drug, there’s no evidence-based strategy to maintain weight loss
This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM Foundation.
Looking at the data from clinical trials of new GLP-1 agonists, it’s clear that patients will need to stay on the drugs to maintain their weight loss, experts said.
At the same time, there’s a dearth of evidence as to whether strategies to mitigate weight regain — such as weaning people from the medications — might help, clinicians and researchers told MedPage Today.
“We generally do expect that when folks discontinue this medication they’ll gain at least some weight back,...
Today's Sponsors
Today's Sponsor